Literature DB >> 26212207

Distribution of intestinal stem cell markers in colorectal precancerous lesions.

Bo Gun Jang1, Hye Sung Kim1, Kyung Ju Kim2, Ye-Young Rhee2, Woo Ho Kim2, Gyeong Hoon Kang2,3.   

Abstract

AIMS: Intestinal stem cell (ISC) markers such as LGR5, ASCL2, EPHB2 and OLFM4, and their clinical implications have been studied extensively in colorectal cancers (CRCs). However, little is known about their expression in precancerous lesions of CRCs. Here, we investigated the expression and distribution of ISC markers in serrated polyps and conventional adenomas. METHODS AND
RESULTS: Reverse transcription-polymerase chain reaction (RT-PCR) analysis revealed that all ISC markers were up-regulated significantly in conventional adenomas with low-grade dysplasia (CALGs) compared with other lesions. RNA in-situ hybridization confirmed that CALGs exhibited strong and diffuse expression of all ISC markers, which indicate a stem cell-like phenotype. However, normal colonic mucosa, hyperplastic polyps and sessile serrated adenomas harboured LGR5(+) cells that were confined to the crypt base and demonstrated an organized expression of ISC markers. Notably, in traditional serrated adenomas, expression of LGR5 and ASCL2 was localized to the ectopic crypts as in the normal crypts, but expression of EPHB2 and OLFM4 was distributed in a diffuse manner, which is suggestive of a progenitor-like features.
CONCLUSIONS: The expression and distribution profile of ISC markers possibly provides insights into the organization of stem and progenitor-like cells in each type of precancerous lesion of CRC.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  LGR5; adenoma; colorectal cancer; in-situ hybridization; stem cells

Mesh:

Substances:

Year:  2015        PMID: 26212207     DOI: 10.1111/his.12787

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

2.  Distinct expression profile of stem cell markers, LGR5 and LGR6, in basaloid skin tumors.

Authors:  Bo Gun Jang; Cheol Lee; Hye Sung Kim; Myung Soo Shin; Min Seok Cheon; Jae Wang Kim; Woo Ho Kim
Journal:  Virchows Arch       Date:  2017-01-09       Impact factor: 4.064

3.  Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus.

Authors:  James Y Dai; Jean de Dieu Tapsoba; Matthew F Buas; Harvey A Risch; Thomas L Vaughan
Journal:  Am J Hum Genet       Date:  2016-08-04       Impact factor: 11.025

4.  DCLK1 Expression in Colorectal Polyps Increases with the Severity of Dysplasia.

Authors:  Aki Takiyama; Toshiaki Tanaka; Shinsuke Kazama; Hiroshi Nagata; Kazushige Kawai; Keisuke Hata; Kensuke Otani; Takeshi Nishikawa; Kazuhito Sasaki; Manabu Kaneko; Shigenobu Emoto; Koji Murono; Hirotoshi Takiyama; Hiroaki Nozawa
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

5.  Identification, isolation and characterization of human LGR5-positive colon adenoma cells.

Authors:  Michael K Dame; Durga Attili; Shannon D McClintock; Priya H Dedhia; Peter Ouillette; Olaf Hardt; Alana M Chin; Xiang Xue; Julie Laliberte; Erica L Katz; Gina M Newsome; David R Hill; Alyssa J Miller; Yu-Hwai Tsai; David Agorku; Christopher H Altheim; Andreas Bosio; Becky Simon; Linda C Samuelson; Jay A Stoerker; Henry D Appelman; James Varani; Max S Wicha; Dean E Brenner; Yatrik M Shah; Jason R Spence; Justin A Colacino
Journal:  Development       Date:  2018-03-14       Impact factor: 6.862

6.  Temporal and spatial changes of cells positive for stem-like markers in different compartments and stages of human colorectal adenoma-carcinoma sequence.

Authors:  Guanglin Cui; Gang Xu; Li Zhu; Zhigang Pang; Wei Zheng; Zhenfeng Li; Aping Yuan
Journal:  Oncotarget       Date:  2017-07-11

7.  Expression profile of intestinal stem cell markers in colitis-associated carcinogenesis.

Authors:  Hye Sung Kim; Cheol Lee; Woo Ho Kim; Young Hee Maeng; Bo Gun Jang
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

8.  OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages.

Authors:  Marie-Alice Meuwis; Edouard Louis; Florence Quesada-Calvo; Charlotte Massot; Virginie Bertrand; Rémi Longuespée; Noëlla Blétard; Joan Somja; Gabriel Mazzucchelli; Nicolas Smargiasso; Dominique Baiwir; Marie-Claire De Pauw-Gillet; Philippe Delvenne; Michel Malaise; Carla Coimbra Marques; Marc Polus; Edwin De Pauw
Journal:  Clin Proteomics       Date:  2017-03-24       Impact factor: 3.988

9.  GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas.

Authors:  Hye Sung Kim; Myung Soo Shin; Min Seok Cheon; Jae Wang Kim; Cheol Lee; Woo Ho Kim; Young Sill Kim; Bo Gun Jang
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

Review 10.  Olfactomedin-4 in digestive diseases: A mini-review.

Authors:  Xin-Yu Wang; Sheng-Hui Chen; Ya-Nan Zhang; Cheng-Fu Xu
Journal:  World J Gastroenterol       Date:  2018-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.